North Texas Veterans Healthcare System

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, North Texas Veterans Healthcare System sits in the top decile of US sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count).

23 total trials none currently recruiting 19 completed later-stage tilt top decile by trial count

North Texas Veterans Healthcare System: 23 sponsored US clinical trials, none currently recruiting.

North Texas Veterans Healthcare System sponsors 23 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 19 completed. 10 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Radiation Monitoring, with 1 trials.

Top-decile sponsor footprint

North Texas Veterans Healthcare System ranks in the top decile of sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 46/100

19 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

23 total, page 1 of 1

COMPLETED NA

Neural Control and Cardiac-Vascular Function in Women With PTSD (VA Psychological Assessment)

NCT03929939
COMPLETED Phase 4

Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial

NCT02510547
COMPLETED NA

Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter

NCT02480569
COMPLETED

Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient

NCT02387658
TERMINATED NA

Excellence in Peripheral Arterial Disease Treatment of Superficial Femoral Artery Disease With Drug-eluting Stents

NCT03671655
TERMINATED NA

Micropuncture vs. Standard Common Femoral Artery Access

NCT02026180
TERMINATED NA

Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)

NCT01962740
COMPLETED Phase 3

Effect of a Real Time Radiation Monitoring Device on Radiation Exposure During Cardiac Catheterization

NCT01510353
COMPLETED Phase 3

RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial

NCT01446263
COMPLETED NA

A Pilot Exercise Study for PTSD in Women Veterans

NCT01892033
TERMINATED Phase 4

Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery

NCT01288105
COMPLETED Phase 2

Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis

NCT01221402
COMPLETED Phase 4

AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study

NCT01012869
COMPLETED Phase 4

Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed

NCT01121458
COMPLETED Phase 4

Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions

NCT00911976
COMPLETED NA

Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease

NCT00827853
COMPLETED NA

Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)

NCT00781573
COMPLETED Phase 3

Laparoscopic Sleeve Gastrectomy With and Without Omentectomy

NCT00434525
COMPLETED Phase 3

Laparoscopic Adjustable Gastric Banding Versus Laparoscopic Sleeve Gastrectomy

NCT00434655
COMPLETED

Evaluation of Protein in the Urine in Patients Receiving Bevacizumab

NCT00849394
COMPLETED Phase 2

The Effect of Human Recombinant Erythropoietin in Acute Renal Failure

NCT03102021
COMPLETED Phase 3

The SOS (Stenting Of Saphenous Vein Grafts) Trial

NCT00247208
COMPLETED

Incidence of Phantom Limb Pain and Method of Anesthesia After Lower Extremity Amputation

NCT01003704

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 5
Phase 4 5

Therapeutic Areas

Radiation Monitoring 1
Coronary Occlusions 1
Morbid Obesity 1
Radiation Protection 1
Peripheral Vascular Disease 1
Vascular Access Complication 1
Post Traumatic Stress Disorder 1

How the North Texas Veterans Healthcare System archive is shaped

23 indexed studies, none listed as recruiting (0% open); 19 completed (83%).

Phase mix: 10 late (III/IV) vs 2 early (I/II) (later-stage heavy).

Top condition: Radiation Monitoring (1 trial), 6 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

North Texas Veterans Healthcare System: archived-pipeline peers nationwide

Peers matched on 23 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

North Texas Veterans Healthcare System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0510152025 0%5%10%15%20%25% Total trials Recruiting share North Texas Veterans Healthcare SystemAMAG PharmaceuticalsAtriCureCara TherapeuticsCraig L Slingluff, Jr10xBio22nd Century Group23andMe3-C Institute for Social Development
North Texas Veterans Healthcare System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

North Texas Veterans Healthcare System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 23 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this North Texas Veterans Healthcare System page

23 registered trials is a research-attention snapshot, not an endorsement of North Texas Veterans Healthcare System or any single study.

  • None of North Texas Veterans Healthcare System's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Radiation Monitoring is the condition North Texas Veterans Healthcare System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Radiation Monitoring trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. North Texas Veterans Healthcare System pipeline card: 23 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.